Results

Total Results: 1,613 records

Showing results for "adverse events".
Users also searched for: patient safety indicators

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-neuropathy_research.pdf
    March 01, 2018 - Comparison of the sample size, primary outcome, and withdrawals due to adverse events reported in the … ClinicalTrials.gov began to mandate reporting of adverse events in September 2009 as serious adverseevents and non-serious adverse events. … We compared the total adverse events reported in ClinicalTrials.gov with the total reported in the … CT.gov reported more adverse events.
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/disposition-of-comments-cer-192-anxiety-in-children.pdf
    August 31, 2017 - This is particularly a problem for rare adverse events. … Studies are required to report any adverse events that occur during study participation; however, … For withdrawals, we reported overall withdrawals and withdrawals due to adverse events. … TEP 3 Results I believe there was a line that stated there were no serious adverse events in the … Nevertheless, we present each specific adverse events so that readers can make these judgments on
  3. effectivehealthcare.ahrq.gov/sites/default/files/pdf/migraine-treatments-research-amended-protocol.pdf
    January 09, 2020 - In addition to effectiveness, decisionmakers need information on potential adverse risks, and special … Pain, function, pain relief satisfaction and quality of life, harms/adverse events (including withdrawal … events KQ 3: Non-invasive non-pharm Therapy: Pain, function, pain relief satisfaction, quality of … life and quality of life, harms, adverse events None Timing At the following intervals: < 1 day … events in patients with migraine.
  4. Gout Executive (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout_executive.pdf
    March 01, 2016 - KQ1, 2 KQ1, 2 Adverse Events Discon�nua�on of An�-inflammatory Therapy KQ5b KQ5b (including presence … Observational studies were also included for rare adverse events. … The most commonly reported adverse events in trials of febuxostat were abdominal pain, diarrhea, and … • High-strength evidence supports a lack of difference in overall adverse events between allopurinol … Adverse events associated with colchicine drug interactions: Analysis of the public version of the
  5. effectivehealthcare.ahrq.gov/products/high-cholestorol-medicines-update/research-protocol
    May 17, 2013 - events when compared with statin monotherapy. … events (SAEs) associated with coadministration of different lipid-modifying agents compared with higher … The CER will examine surrogate markers of CHD events including lipid levels and atherosclerosis, as well … Ridker PM, Rifai N, Pfeffer MA, et al; Cholesterol and Recurrent Events Investigators. … Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.
  6. effectivehealthcare.ahrq.gov/sites/default/files/pdf/high-cholestorol-medicines-update_research-protocol.pdf
    December 31, 2013 - events when compared with statin monotherapy. … The CER will examine surrogate markers of CHD events including lipid levels and atherosclerosis, as … Ridker PM, Rifai N, Pfeffer MA, et al; Cholesterol and Recurrent Events Investigators. … Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol … Rosuvastatin to  prevent vascular events in men and women with elevated C-­‐reactive protein.
  7. effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoporosis-bone-fracture_research-protocol.pdf
    May 14, 2010 - events will be analyzed for KQ4 … • Outcomes: - Any reported harms/adverse events (AEs) that can be directly associated with use … KQ4 assesses the evidence for adverse effects of treatment. … Events.9 Then, a verbatim account of the AE will be recorded on the form. … Common Terminology Criteria for Adverse Events (CTCAE). Version 4.0.
  8. effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-surveillance_research-protocol.pdf
    May 19, 2011 - However, both surgical and radiation treatments result in significant short- and long-term adverseevents. … Thus, all men who undergo treatment risk suffering the adverse events of the treatment, while only … events, and costs. … Randomized controlled trials, nonrandomized comparative studies, and cohort studies; for adverse events
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/antibiotics-respiratory-infection_executive.pdf
    January 01, 2016 - drug events, and decreased health care costs. … events along with overall prescribing. … events and efficacy (N = 1 RCT). … events (N = 1 RCT). … Since the absolute numbers of events were low, the estimates are likely to be unstable and could change
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/evidence-summary-cer-199-skin-cancer.pdf
    December 01, 2017 - • Serious adverse events, events leading to treatment discontinuation, and treatment site infections … Adverse Events, All BCC Lesions In Table B drugs were most likely to have adverse events leading to … Events Leading to Discontinuation (95% CI) Serious Adverse Events (95% CI) Adverse Events: … Adverse Events, All SCCIS Lesions In Table C the highest mean frequency of adverse events leading to … Adverse events were inconsistently reported.
  11. effectivehealthcare.ahrq.gov/products/major-depressive-disorder/research-protocol
    June 19, 2014 - events are uncommon for most CAM treatments, but concern exists for potential drug interactions between … events (safety and tolerability): overall adverse events, withdrawals because of adverse events, serious … adverse events, specific adverse events (including hyponatremia, seizures, suicidality, hepatotoxicity … events, results, and adverse events reported. … events, if reported.
  12. effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c_research-protocol.pdf
    November 30, 2011 - dosages and durations of treatment according to various factors. 10 A common (50 to 60 percent) adverse … In addition, psychiatric, gastrointestinal, dermatological, and hematologic adverse effects underlie … effects of intervention(s)  Harms from antiviral treatment, including withdrawals due to adverseevents, serious adverse events such as severe neutropenia, psychological adverse events, flu-like … symptoms, and hematological adverse events Timing and Setting: No minimum timing and all settings
  13. effectivehealthcare.ahrq.gov/products/head-neck-cancer-update/research-protocol
    February 04, 2014 - Evidence was insufficient to draw relative conclusions on survival or tumor control; adverse events other … Other tools used to assess adverse events include the Subjective, Objective, Management, Analytic (SOMA … Treatment-associated adverse events assume greater importance in patients identified with HPV as the … Outcomes KQ 1, 3 & 4: Final outcomes : QoL and adverse events including; radiation induced toxicities … Also, adverse events such as radiation-associated xerostomia and salivary dysfunction, dysphagia, mucositis
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/tympanostomy-tubes-disposition.pdf
    May 05, 2017 - events of tubes without stating adverse events of comparative strategies), which I would urge the … Our descriptive survey of adverse events associated with TT directly reflects KQ 3 "what adverse events … and adverse events (“a variety of adverse events” is not very specific, the authors should specify … adverse events). Edited to provide specific time frames for KQ 1. … adverse events rather than providing a Table only.
  15. effectivehealthcare.ahrq.gov/sites/default/files/tympanostomy-tubes-disposition.pdf
    May 05, 2017 - events of tubes without stating adverse events of comparative strategies), which I would urge the … Our descriptive survey of adverse events associated with TT directly reflects KQ 3 "what adverse events … and adverse events (“a variety of adverse events” is not very specific, the authors should specify … adverse events). Edited to provide specific time frames for KQ 1. … adverse events rather than providing a Table only.
  16. effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine-prevention_executive.pdf
    June 01, 2013 - For categorical variables we abstracted the number of events among treatment groups to calculate rates … The number of avoided or excess events per population of 1,000 was the difference between the two event … effects, (2) strength of evidence, and (3) number of events attributable to drug administration per … Few clinical trials followed the recommendations from the Task Force on Adverse Events in Migraine … Evaluation and registration of adverse events in clinical drug trials in migraine.
  17. effectivehealthcare.ahrq.gov/products/preterm-birth-terbutaline-pump/research
    September 29, 2011 - for bronchopulmonary dysplasia, incidence of delivery <28 weeks and <34 weeks, and withdrawals due to adverseevents. … Until 2009, several cases of maternal deaths and maternal cardiovascular events in association with terbutaline
  18. effectivehealthcare.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-medicine_research-protocol.pdf
    December 06, 2010 - Many questions remain about the risks of these agents across a spectrum of adverse events—from relatively … 3: For patients with RA, do drug therapies differ in harms, tolerability, patient adherence, or adverse … Morbidity, mortality, and other serious adverse events ii. Tolerability iii. Adherence iv. … Other adverse effects • Timing: Minimum of 3 months of follow-up • Settings: Primary care … Also, adverse events may occur at any point after the treatment is received. IV. Methods A.
  19. effectivehealthcare.ahrq.gov/sites/default/files/pdf/acs-depression-research-protocol-amended.pdf
    February 15, 2017 - events associated with pharmacologic and/or nonpharmacologic treatments (KQ 2). … events outcomes). … The safety outcomes will be framed to help identify adverse events, including those from drug therapies … interest; that is, important characteristics are those that affect baseline (control group) rates of events … , intervention group rates of events, or both.
  20. effectivehealthcare.ahrq.gov/sites/default/files/related_files/nephropathy-contrast-induced_executive-2016.pdf
    January 01, 2016 - events, mortality, imaging quality, and diagnostic accuracy. … Food and Drug Administration Adverse Event Reporting System (AERS). … events, imaging quality, and diagnostic accuracy. … events (12 studies), or image and diagnostic quality (2 studies). … , mortality, need for renal replacement therapy, or other adverse events.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: